Article info
PDFClinical trials and drug discovery
Evaluating duration of response to treatment in systemic lupus erythematosus clinical trials
- Correspondence to Dr Mimi Kim; mimi.kim{at}einstein.yu.edu
Citation
Evaluating duration of response to treatment in systemic lupus erythematosus clinical trials
Publication history
- Received April 11, 2018
- Revision received May 23, 2018
- Accepted June 17, 2018
- First published August 6, 2018.
Online issue publication
May 01, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/